Search

Search Constraints

You searched for: Author/Creator Guillaume, Thierry

Search Results

1. 90Y-labelled anti-CD22 epratuzumab tetraxetan in adults with refractory or relapsed CD22-positive B-cell acute lymphoblastic leukaemia: a phase 1 dose-escalation study. Issue 3 (March 2015)

2. A new cytokine‐based dynamic stratification during induction is highly predictive of survivals in acute myeloid leukemia. (25th December 2020)

3. A novel complete blood count‐based score to screen for myelodysplastic syndrome in cytopenic patients. (8th November 2018)

4. A phase I/II feasibility vaccine study by autologous leukemic apoptotic corpse-pulsed dendritic cells for elderly AML patients. Issue 10 (3rd October 2021)

5. Allogeneic hematopoietic stem cell transplantation for T‐prolymphocytic leukemia: a report from the French society for stem cell transplantation (SFGM‐TC). (13th September 2014)

6. Anti‐SARS‐CoV‐2 vaccines in recipient and/or donor before allotransplant. Issue 2 (17th February 2022)

7. Azacitidine in patients older than 80 years with acute myeloid leukaemia or myelodysplastic syndromes: a report on 115 patients. (11th May 2020)

8. BCR‐ABL1 molecular remission after 90Y‐epratuzumab tetraxetan radioimmunotherapy in CD22+ Ph+ B‐ALL: proof of principle. (12th September 2013)

9. Characterization of various blood and graft sources: a prospective series. Issue 9 (16th January 2013)

10. Clofarabine versus fludarabine‐based reduced‐intensity conditioning regimen prior to allogeneic transplantation in adults with AML/MDS. (17th October 2016)